PDCO
41
3
UNP
48
6
FOXA
63
3
RRC
50
4
AMAT
46
6
PSA
56
5
XYL
35
4
L
51
5
XOM
42
2
ESS
56
5
TXN
43
-3
HRB
56
2
HST
63
5
DOV
61
4
STI
28
9
C
54
4
EMC
71
9
SYF
83
4
QRVO
4
2
INTC
44
5
PDCO
41
3
UNP
48
6
FOXA
63
3
RRC
50
4
AMAT
46
6
PSA
56
5
XYL
35
4
L
51
5
XOM
42
2
ESS
56
5
TXN
43
-3
HRB
56
2
HST
63
5
DOV
61
4
STI
28
9
C
54
4
EMC
71
9
SYF
83
4
QRVO
4
2
INTC
44
5
Financhill
Back

LakeShore Biopharma 10K Form

Sell
27

LSB
LakeShore Biopharma

Last Price:
2.19
Seasonality Move:
-0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LSB News And Ratings

See the #1 stock for the next 7 days that we like better than LSB

LSB Financial Statistics

Sales & Book Value

Annual Sales: $80.21M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.82
Price / Book: 0

Profitability

EPS (TTM): -0.39800
Net Income (TTM): $-26.16M
Gross Margin: $63.74M
Return on Equity: 0%
Return on Assets: 0%

LakeShore Biopharma Earnings Forecast

Key LakeShore Biopharma Financial Ratios

  • The Gross Profit Margin over the past 4 years for LSB is 79.48%.
  • The Selling, General & Administrative Expenses for LSB have been equal to 74.66% of Gross Profit Margin.
  • The Research & Development expenses have been 52.81% of Revenue.
  • The Interest Expense is -10.23% of Operating Income.
  • The Net Earning history of LSB is -75.59% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

LakeShore Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LSB
Website: lakeshorebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LSB Technical Analysis vs Fundamental Analysis

Sell
27
LakeShore Biopharma (LSB) is a Sell

Is LakeShore Biopharma a Buy or a Sell?